8:36 am OncoMed Pharma commences third Phase 1b clinical trial for OMP-54F28 (Fzd8-Fc) with carboplatin and paclitaxel in ovarian cancer; all six planned Wnt-pathway Phase 1b studies now underway
View todays social media effects on OMED
View the latest stocks trending across Twitter. Click to view dashboard
See who OncoMed is hiring next, click here to view
